View Item 

Show simple item record

Optimizing cardiovascular and chemopreventive benefits of aspirin: what role for the proton-pump inhibitors?
dc.contributor.authorScheiman, James M.en_US
dc.date.accessioned2010-06-01T22:36:25Z
dc.date.available2010-06-01T22:36:25Z
dc.date.issued2005-03en_US
dc.identifier.citationSCHEIMAN, J. (2005). "Optimizing cardiovascular and chemopreventive benefits of aspirin: what role for the proton-pump inhibitors?." Alimentary Pharmacology & Therapeutics 21(s1): 7-8. <http://hdl.handle.net/2027.42/75584>en_US
dc.identifier.issn0269-2813en_US
dc.identifier.issn1365-2036en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/75584
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=15755267&dopt=citationen_US
dc.format.extent70837 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights2005 Blackwell Publishing Ltden_US
dc.titleOptimizing cardiovascular and chemopreventive benefits of aspirin: what role for the proton-pump inhibitors?en_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelOtolaryngologyen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid15755267en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/75584/1/j.1365-2036.2004.02347.x.pdf
dc.identifier.doi10.1111/j.1365-2036.2004.02347.xen_US
dc.identifier.sourceAlimentary Pharmacology & Therapeuticsen_US
dc.identifier.citedreferenceWeisman SM, Graham DY. Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Arch Intern Med 2002; 162: 2197 – 202.en_US
dc.identifier.citedreferenceHayden M, Pignone M, Phillips C, Mulrow C. Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 136: 161 – 72.en_US
dc.identifier.citedreferenceCorley DA, Kerlikowske K, Verma R, Buffler B. Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology 2003; 124: 47 – 56.en_US
dc.identifier.citedreferenceSandler RS, Halabi S, Baron JA, et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 2003; 348: 883 – 90.en_US
dc.identifier.citedreferenceBaron JA, Cole BF, Sandler RS, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003; 348: 891 – 9.en_US
dc.identifier.citedreferenceGarcia Rodriguez LA, Hernandez-Diaz S, de Abajo FJ. Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies. Br J Clin Pharmacol 2001; 52: 563 – 71.en_US
dc.identifier.citedreferenceLai KC, Lam SK, Chu KM, et al. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med 2002; 346: 2033 – 8.en_US
dc.identifier.citedreferenceGoldstein JL, Huang B, Amer F, Christopoulos NG. Ulcer recurrence in high-risk patients receiving nonsteroidal anti-inflammatory drugs plus low-dose aspirin: results of a post-hoc subanalysis. Clin Ther 2004; 26: 1637 – 43.en_US
dc.identifier.citedreferenceChan FK, Chung SC, Suen BY, et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 2001; 344: 967 – 73.en_US
dc.identifier.citedreferenceGraham DY, Agrawal NM, Campbell DR, et al. NSAID-associated gastric ulcer prevention study group. Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs. lansoprazole. Arch Intern Med 2002; 162: 169 – 75.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1365-2036.2004.02347.x.pdf
Size:
69.17KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.